Kalaris Therapeutics, Inc. KLRS
NASDAQ · United States · Health Technology
$2.70-0.15 (-5.26%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.48 | -0.50 | +3.0% | $0 | — | 0.0%$3.94→$3.94 |
| Q1 2026 | 2026-05-12 | -0.46 | -0.52 | +11.5% | — | — | +2.1%$4.73→$4.83 |
| Q4 2025 | 2026-03-17 | -0.44 | -0.55 | +20.0% | — | — | -14.5%$8.81→$7.53 |
| Q3 2025 | 2025-11-12 | -0.64 | -0.66 | +3.0% | — | — | +5.1%$5.07→$5.33 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.